In addition, we analyzed tumor immune infiltration by immunohistochemistry 15 days after viral administration of NP53-bearing mice and observed a significant increase in the CD8+ subpopulation but no increase in CD4+ cells (P = 0.0168 and P = 0.5744, respectively). The gene discussed is CD8A; the disease is neoplasm.